Ubrogepant for the treatment of migraine attacks during the prodrome: a phase 3, multicentre, randomised, double-blind, placebo-controlled, crossover trial in the USA
Authors:
Top Cited Papers
- 15 November 2023
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 402 (10419) , 2307-2316
Abstract
No abstract availableKeywords
Funding Information
- AbbVie
This publication has 29 references indexed in Scilit:
- Localization of CGRP receptor components and receptor binding sites in rhesus monkey brainstem: A detailed study using in situ hybridization, immunofluorescence, and autoradiographyJournal of Comparative Neurology, 2015
- Ineffective acute treatment of episodic migraine is associated with new-onset chronic migraineNeurology, 2015
- Methodological Issues in Studying Trigger Factors and Premonitory Features of MigraineHeadache: The Journal of Head and Face Pain, 2014
- Early vs. Non-Early Intervention in Acute Migraine — ‘Act When Mild (AwM)’. A Double-Blind, Placebo-Controlled Trial of AlmotriptanCephalalgia, 2008
- A Clinical Study of Migraine EvolutionHeadache: The Journal of Head and Face Pain, 2006
- The Prevalence of Premonitory Symptoms in Migraine: A Questionnaire Study in 461 PatientsCephalalgia, 2006
- Sleep quality, chronotypes and preferential timing of attacks in migraine without auraThe Journal of Headache and Pain, 2005
- Headache and Sleep: Examination of Sleep Patterns and Complaints in a Large Clinical Sample of MigraineursHeadache: The Journal of Head and Face Pain, 2005
- Migraine ChronobiologyHeadache: The Journal of Head and Face Pain, 1998
- Domperidone in the prevention of complete classical migraine.BMJ, 1982